Jacob J. Christensen (Norway)

Oslo University Hospital Norwegian National Advisory Unit on Familial Hypercholesterolemia
I am a clinical dietitian and postdoctoral researcher at Oslo University Hospital and University of Oslo. My academic interests span several topics. My main focus is how genetic and lifestyle exposures, such as variation in single nucleotide polymorphisms (SNPs) and dietary fatty acid consumption, affect plasma lipid levels and other cardiovascular disease (CVD) risk factors. My research involves both healthy children and adults, as well as pregnant women and subjects with familial hypercholesterolemia (FH). I am involved in both clinical interventions (for example The NOMA Study) and epidemiological studies (for example The Norwegian Mother, Father and Child Cohort Study and The STORK Study, and studies using the Norwegian national health registries), where my main responsibility is related to data analysis. For example, I apply principles of biostatistics and bioinformatics to leverage knowledge from various omics‑type datasets to examine potential biomarkers of dietary intake or CVD risk. I particularly study the early‑life exposures to elevated levels of CVD risk factors. Additionally, I am part of The Nordic Nutrition Recommendations 2022 (NNR2022) Committee, working on the update of NNR2012, which will form the basis for dietary guidelines in the Nordic and Baltic countries the next decade.

Author Of 2 Presentations

O062 - Children with familial hypercholesterolemia display changes in LDL and HDL function: a cross-sectional study (ID 1406)

Session Type
Late Breaking Sessions
Session Time
10:00 - 11:15
Date
Wed, 02.06.2021
Room
Hall A (Live Q&A)
Lecture Time
10:28 - 10:35

Abstract

Background and Aims

The functional status of lipoprotein particles contributes to atherogenesis. The tendency of plasma LDL particles to aggregate and the ability of HDL particles to induce and mediate reverse cholesterol transport associate with high and low risk for cardiovascular disease in adult patients, respectively. However, it is unknown whether children with familial hypercholesterolemia (FH) display lipoprotein function alterations.

We hypothesized that FH children had disrupted lipoprotein function.

Methods

We analyzed LDL aggregation susceptibility and HDL-apoA-I exchange to apoA-I ratio (HAE/apoA-I ratio), and activity of four proteins that regulate lipoprotein metabolism (CETP, LCAT, PLTP and PON1) in plasma samples derived from children with FH (n = 47) and from healthy children (n = 56). Potential biological mechanisms behind any variation in lipoprotein functionalities were explored using an NMR-based metabolomics profiling approach.

Results

LDL aggregation was higher and HAE/apoA-I ratio was lower in FH children than in healthy children. LDL aggregation associated positively with LDL-C and negatively with triglycerides, and HAE/apoA-I ratio associated negatively with LDL-C. Generally, the metabolomic profile for LDL aggregation was a mirror image of that for HAE/apoA-I ratio.

Conclusions

FH children displayed increased atherogenicity of LDL and disrupted HDL function. These newly observed functional alterations in LDL and HDL may help explain the risk for atherosclerotic cardiovascular disease in FH children.

Hide

Presenter of 2 Presentations

O062 - Children with familial hypercholesterolemia display changes in LDL and HDL function: a cross-sectional study (ID 1406)

Session Type
Late Breaking Sessions
Session Time
10:00 - 11:15
Date
Wed, 02.06.2021
Room
Hall A (Live Q&A)
Lecture Time
10:28 - 10:35

Abstract

Background and Aims

The functional status of lipoprotein particles contributes to atherogenesis. The tendency of plasma LDL particles to aggregate and the ability of HDL particles to induce and mediate reverse cholesterol transport associate with high and low risk for cardiovascular disease in adult patients, respectively. However, it is unknown whether children with familial hypercholesterolemia (FH) display lipoprotein function alterations.

We hypothesized that FH children had disrupted lipoprotein function.

Methods

We analyzed LDL aggregation susceptibility and HDL-apoA-I exchange to apoA-I ratio (HAE/apoA-I ratio), and activity of four proteins that regulate lipoprotein metabolism (CETP, LCAT, PLTP and PON1) in plasma samples derived from children with FH (n = 47) and from healthy children (n = 56). Potential biological mechanisms behind any variation in lipoprotein functionalities were explored using an NMR-based metabolomics profiling approach.

Results

LDL aggregation was higher and HAE/apoA-I ratio was lower in FH children than in healthy children. LDL aggregation associated positively with LDL-C and negatively with triglycerides, and HAE/apoA-I ratio associated negatively with LDL-C. Generally, the metabolomic profile for LDL aggregation was a mirror image of that for HAE/apoA-I ratio.

Conclusions

FH children displayed increased atherogenicity of LDL and disrupted HDL function. These newly observed functional alterations in LDL and HDL may help explain the risk for atherosclerotic cardiovascular disease in FH children.

Hide